Healthcare Global Enterprises Shows Strong Cash Flow Amid Rising Debt Concerns

Healthcare Global Enterprises has recently undergone a financial trend adjustment, reflecting a more stable performance in its latest quarterly results for September 2025. The company reported its highest operating cash flow at Rs 317.11 crore, alongside a notable return on capital employed of 10.86%. Additionally, net sales reached a peak of Rs 646.85 crore, with a corresponding PBDIT of Rs 123.31 crore, indicating strong operational efficiency. The operating profit margin to net sales also stood out at 19.06%, showcasing effective cost management.
However, challenges remain for the company. Interest expenses for the first nine months have risen to Rs 133.26 crore, marking a growth of 20.72%. Furthermore, the debt-equity ratio has reached a concerning 8.01 times, indicating a high level of leverage. The profit after tax for the quarter has also seen a decline, reported at Rs 16.27 crore, down by 9.6%.

In terms of market performance, Healthcare Global has outperformed the Sensex significantly over various periods, including a year-to-date return of 53.4% compared to the Sensex's 8.02%. Over the past five years, the stock has surged by 507.38%, highlighting its strong recovery and growth trajectory in the hospital industry.